Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2014 2
2015 3
2016 3
2017 3
2018 6
2019 5
2020 4
2021 9
2022 10
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Lung cancer is also a hereditary disease.
Benusiglio PR, Fallet V, Sanchis-Borja M, Coulet F, Cadranel J. Benusiglio PR, et al. Among authors: fallet v. Eur Respir Rev. 2021 Oct 20;30(162):210045. doi: 10.1183/16000617.0045-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34670806 Free PMC article. Review.
[Peri-operative management of smoking].
Ruppert AM, Amrioui F, Fallet V, Cadranel J. Ruppert AM, et al. Among authors: fallet v. Rev Pneumol Clin. 2018 Jun;74(3):154-159. doi: 10.1016/j.pneumo.2018.04.007. Epub 2018 May 23. Rev Pneumol Clin. 2018. PMID: 29802008 Review. French.
[Pulmonary sarcomatoid carcinoma].
Antoine M, Vieira T, Fallet V, Hamard C, Duruisseaux M, Cadranel J, Wislez M. Antoine M, et al. Among authors: fallet v. Ann Pathol. 2016 Jan;36(1):44-54. doi: 10.1016/j.annpat.2015.11.007. Epub 2016 Jan 8. Ann Pathol. 2016. PMID: 26778815 Review. French.
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer.
Chour A, Denis J, Mascaux C, Zysman M, Bigay-Game L, Swalduz A, Gounant V, Cortot A, Darrason M, Fallet V, Auclin E, Basse C, Tissot C, Decroisette C, Bombaron P, Giroux-Leprieur E, Odier L, Brosseau S, Creusot Q, Gueçamburu M, Meersseman C, Rochand A, Costantini A, Gaillard CM, Wasielewski E, Girard N, Cadranel J, Lafitte C, Lebossé F, Duruisseaux M. Chour A, et al. Among authors: fallet v. J Thorac Oncol. 2023 Oct;18(10):1408-1415. doi: 10.1016/j.jtho.2023.05.013. Epub 2023 May 20. J Thorac Oncol. 2023. PMID: 37217096
Invited editorial: Q and A on hereditary lung cancer.
Benusiglio PR, Fallet V, Cadranel J. Benusiglio PR, et al. Among authors: fallet v. Respir Med Res. 2022 May;81:100881. doi: 10.1016/j.resmer.2021.100881. Epub 2022 Apr 30. Respir Med Res. 2022. PMID: 35504062
[Lung cancer in HIV-infected patients].
Domblides C, Canellas A, Wislez M, Fallet V, Antoine M, Crequit P, Cadranel J, Lavolé A. Domblides C, et al. Among authors: fallet v. Bull Cancer. 2018 Jan;105(1):111-119. doi: 10.1016/j.bulcan.2017.11.002. Epub 2017 Dec 22. Bull Cancer. 2018. PMID: 29269175 Review. French.
[Nivolumab, a new hope in non-small cell lung cancer].
Flippot R, Fallet V, Besse B, Massard C, Wislez M, Vignot S. Flippot R, et al. Among authors: fallet v. Bull Cancer. 2015 Dec;102(12):1046-52. doi: 10.1016/j.bulcan.2015.10.005. Epub 2015 Nov 14. Bull Cancer. 2015. PMID: 26585939 Review. French.
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
Panhaleux M, Espitia O, Terrier B, Manson G, Maria A, Humbert S, Godbert B, Perrin J, Achille A, Arrondeau J, Kostine M, Fallet V, Pugnet G, Chaigne B, Champiat S, Laparra A, Danlos FX, Launay D, Penel N, Lambotte O, Michot JM, Forestier A. Panhaleux M, et al. Among authors: fallet v. Eur J Cancer. 2022 Jan;160:134-139. doi: 10.1016/j.ejca.2021.10.018. Epub 2021 Nov 19. Eur J Cancer. 2022. PMID: 34810048 Clinical Trial.
48 results